In-Vitro Assay Modelling For Potential Cancer Immunotherapies

In this 30 min presentation, Dr Frances Acklam, Senior Scientist at CLS, will present our capabilities and solutions we provide within the I-O drug discovery space with a specific focus on two types of in vitro platform assays: exhausted T cell assay and tumour associated macrophage assays. T cell and macrophages are critical players in the tumour microenvironment and constitute major cellular targets in immunotherapy. We will demonstrate how we have established robust laboratory assays using human T cells and macrophages and how we can use these assays to identify promising compounds that would benefit cancer patients.

Fill in the form to watch the full webinar.

Please fill in this form to access the full resource